This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Industry News
  • London-based My i-Clinic offers cutting-edge CAIRS treatment for keratoconus

London-based My i-Clinic offers cutting-edge CAIRS treatment for keratoconus

24 October 2024 | Company Profiles, Research & Development
Share This

 

Revolutionary treatment paves the way for reducing cases of degenerative eye condition

My i-Clinic is spearheading the treatment of keratoconus after adopting the innovative ‘CAIRS’ procedure to treat patients. Hailed as a game-changer by experts, the minimally invasive procedure is designed to both strengthen and reshape the cornea of those living with this progressive eye condition.

 

 

Mr Radwan Almousa, Corneal Surgeon at My i-clinic, says: “Depending on how severe the condition is, keratoconus is typically treated with glasses, contact lenses, implantable ring segments (ICRS), collagen crosslinking, or cornea transplants. Yet, the procedure for ICRS, for example, has multiple, potential side effects such as inflammation and melting of the cornea, which can result in the intrusion or extrusions of the rings.

“CAIRS was developed as an alternative to ICRS, but our experience with CAIRS so far has proven it to be free of most of the complications of ICRS and generally brings about a level of improvement in vision far beyond that experienced with ICRS. We are finding this to be the case for a larger range of patients.

“The 20-minute procedure offers a much faster recovery period and far fewer risks than traditional cornea surgery, yet is currently only available at a handful of clinics in the UK. We’re excited about the transformational potential to finally provide long-term respite to patients with CAIRS.”

 

FURTHER INFORMATION:

Please visit https://www.my-iclinic.co.uk/cairs

Share This
Select an News/Industy Category
  • Awards, Conferences & Anniversaries
  • Company Profiles
  • Contracts & Distributors
  • Global Health
  • Recruitment & Personnel
  • Research & Development
Keyword Search

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency